@AMAManual Hi,
With FDA-approved biologic generics, there is a nonsense, 4-letter extension appended to the drug name. For example, lecanemab-irmb (Leqembi). In text, would you include the 4-letter extension on second and subsequent mentions of the drug?
@AMAManual Yes, we agree about the link. Thank you!
I'm not sure about hosting a publicly accessible file; that's beyond copyeditor remit for this assignment.
(Heh-heh, too bad companies don't use doi numbers.)